Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and SLC25A13 mutations among Thai infants

Suporn Treepongkaruna1, Suttiruk Jitraruch, Porawee Kodcharin

  • 1Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.

BMC Gastroenterology
|October 17, 2012
PubMed

Insights

Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is often misdiagnosed. This study found NICCD in 12.8% of Thai infants with idiopathic cholestatic jaundice, suggesting it should be considered in diagnosis.

Area of Science:

  • Genetics and Molecular Biology
  • Pediatric Gastroenterology
  • Metabolic Disorders

Background:

  • Idiopathic neonatal hepatitis (INH) and biliary atresia are common causes of infant cholestatic jaundice.
  • Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), linked to SLC25A13 gene mutations, is increasingly identified, particularly in East Asian populations.
  • NICCD is often misdiagnosed as INH due to spontaneous recovery, complicating prevalence assessment.

Purpose of the Study:

  • To determine the prevalence of NICCD and SLC25A13 mutations in Thai infants.
  • To compare clinical and biochemical characteristics of NICCD and non-NICCD infants.
  • To investigate the genetic basis of NICCD in a Thai cohort.

Main Methods:

  • Enrolled infants with idiopathic cholestatic jaundice or INH.
  • Reviewed clinical and biochemical data, including urine organic acid and plasma amino acid profiles.
  • Performed PCR-sequencing of all 18 exons of the SLC25A13 gene and gap PCR for specific mutations.

Main Results:

  • NICCD was identified in 5 out of 39 (12.8%) infants, with common mutations including 851del4.
  • NICCD patients presented with higher alkaline phosphatase (ALP), alpha-fetoprotein (AFP), and lower alanine aminotransferase (ALT) compared to non-NICCD infants.
  • NICCD infants showed elevated citrulline levels and threonine/serine ratios, with jaundice resolving in all NICCD cases.

Conclusions:

  • NICCD is a significant consideration for infants presenting with idiopathic cholestasis.
  • The estimated prevalence of NICCD in Thai infants is 1/48,228, with a carrier rate of 1/110.
  • Further research with larger populations is needed to confirm the true prevalence of NICCD and AGC2 deficiency.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...